Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 290

1.

A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity.

Béziat V, Li J, Lin JX, Ma CS, Li P, Bousfiha A, Pellier I, Zoghi S, Baris S, Keles S, Gray P, Du N, Wang Y, Zerbib Y, Lévy R, Leclercq T, About F, Lim AI, Rao G, Payne K, Pelham SJ, Avery DT, Deenick EK, Pillay B, Chou J, Guery R, Belkadi A, Guérin A, Migaud M, Rattina V, Ailal F, Benhsaien I, Bouaziz M, Habib T, Chaussabel D, Marr N, El-Benna J, Grimbacher B, Wargon O, Bustamante J, Boisson B, Müller-Fleckenstein I, Fleckenstein B, Chandesris MO, Titeux M, Fraitag S, Alyanakian MA, Leruez-Ville M, Picard C, Meyts I, Di Santo JP, Hovnanian A, Somer A, Ozen A, Rezaei N, Chatila TA, Abel L, Leonard WJ, Tangye SG, Puel A, Casanova JL.

Sci Immunol. 2018 Jun 15;3(24). pii: eaat4956. doi: 10.1126/sciimmunol.aat4956.

PMID:
29907691
2.

ZNF341 controls STAT3 expression and thereby immunocompetence.

Frey-Jakobs S, Hartberger JM, Fliegauf M, Bossen C, Wehmeyer ML, Neubauer JC, Bulashevska A, Proietti M, Fröbel P, Nöltner C, Yang L, Rojas-Restrepo J, Langer N, Winzer S, Engelhardt KR, Glocker C, Pfeifer D, Klein A, Schäffer AA, Lagovsky I, Lachover-Roth I, Béziat V, Puel A, Casanova JL, Fleckenstein B, Weidinger S, Kilic SS, Garty BZ, Etzioni A, Grimbacher B.

Sci Immunol. 2018 Jun 15;3(24). pii: eaat4941. doi: 10.1126/sciimmunol.aat4941.

PMID:
29907690
3.

Dual T cell- and B cell-intrinsic deficiency in humans with biallelic RLTPR mutations.

Wang Y, Ma CS, Ling Y, Bousfiha A, Camcioglu Y, Jacquot S, Payne K, Crestani E, Roncagalli R, Belkadi A, Kerner G, Lorenzo L, Deswarte C, Chrabieh M, Patin E, Vincent QB, Müller-Fleckenstein I, Fleckenstein B, Ailal F, Quintana-Murci L, Fraitag S, Alyanakian MA, Leruez-Ville M, Picard C, Puel A, Bustamante J, Boisson-Dupuis S, Malissen M, Malissen B, Abel L, Hovnanian A, Notarangelo LD, Jouanguy E, Tangye SG, Béziat V, Casanova JL.

J Exp Med. 2016 Oct 17;213(11):2413-2435. Epub 2016 Sep 19.

4.

Transduction of Herpesvirus saimiri-Transformed T Cells with Exogenous Genes of Interest.

Martínez-Barricarte R, de Jong SJ, Markle J, de Paus R, Boisson-Dupuis S, Bustamante J, van de Vosse E, Fleckenstein B, Casanova JL.

Curr Protoc Immunol. 2016 Nov 1;115:7.21C.1-7.21C.12. doi: 10.1002/cpim.15.

PMID:
27801513
5.

Fatal Lymphoproliferative Disease in Two Siblings Lacking Functional FAAP24.

Daschkey S, Bienemann K, Schuster V, Kreth HW, Linka RM, Hönscheid A, Fritz G, Johannes C, Fleckenstein B, Kempkes B, Gombert M, Ginzel S, Borkhardt A.

J Clin Immunol. 2016 Oct;36(7):684-92. doi: 10.1007/s10875-016-0317-y. Epub 2016 Jul 29.

PMID:
27473539
6.

Specific antibody deficiency and autoinflammatory disease extend the clinical and immunological spectrum of heterozygous NFKB1 loss-of-function mutations in humans.

Schipp C, Nabhani S, Bienemann K, Simanovsky N, Kfir-Erenfeld S, Assayag-Asherie N, Oommen PT, Revel-Vilk S, Hönscheid A, Gombert M, Ginzel S, Schäfer D, Laws HJ, Yefenof E, Fleckenstein B, Borkhardt A, Stepensky P, Fischer U.

Haematologica. 2016 Oct;101(10):e392-e396. Epub 2016 Jun 30. No abstract available.

7.

Frequent occurrence of therapeutically reversible CMV-associated encephalopathy during radiotherapy of the brain.

Goerig NL, Frey B, Korn K, Fleckenstein B, Überla K, Schmidt MA, Dörfler A, Engelhorn T, Eyüpoglu I, Rühle PF, Putz F, Semrau S, Gaipl US, Fietkau R.

Neuro Oncol. 2016 Dec;18(12):1664-1672. Epub 2016 Jun 10.

8.

Clinically significant CMV (re)activation during or after radiotherapy/chemotherapy of the brain : Correlation with neurological deterioration and improvement upon antiviral treatment.

Goerig N, Semrau S, Frey B, Korn K, Fleckenstein B, Überla K, Dörfler A, Putz F, Gaipl US, Fietkau R.

Strahlenther Onkol. 2016 Jul;192(7):489-97. doi: 10.1007/s00066-016-0987-7. Epub 2016 May 31.

PMID:
27245820
9.

In-situ measurement of oxygen concentration under high pressure and the application to oxygen permeation through polymer films.

Sterr J, Rötzer K, Weck K, Wirth AL, Fleckenstein BS, Langowski HC.

J Chem Phys. 2015 Sep 21;143(11):114201. doi: 10.1063/1.4931399.

PMID:
26395698
10.

Human TYK2 deficiency: Mycobacterial and viral infections without hyper-IgE syndrome.

Kreins AY, Ciancanelli MJ, Okada S, Kong XF, Ramírez-Alejo N, Kilic SS, El Baghdadi J, Nonoyama S, Mahdaviani SA, Ailal F, Bousfiha A, Mansouri D, Nievas E, Ma CS, Rao G, Bernasconi A, Sun Kuehn H, Niemela J, Stoddard J, Deveau P, Cobat A, El Azbaoui S, Sabri A, Lim CK, Sundin M, Avery DT, Halwani R, Grant AV, Boisson B, Bogunovic D, Itan Y, Moncada-Velez M, Martinez-Barricarte R, Migaud M, Deswarte C, Alsina L, Kotlarz D, Klein C, Muller-Fleckenstein I, Fleckenstein B, Cormier-Daire V, Rose-John S, Picard C, Hammarstrom L, Puel A, Al-Muhsen S, Abel L, Chaussabel D, Rosenzweig SD, Minegishi Y, Tangye SG, Bustamante J, Casanova JL, Boisson-Dupuis S.

J Exp Med. 2015 Sep 21;212(10):1641-62. doi: 10.1084/jem.20140280. Epub 2015 Aug 24.

11.

Deregulation of Fas ligand expression as a novel cause of autoimmune lymphoproliferative syndrome-like disease.

Nabhani S, Ginzel S, Miskin H, Revel-Vilk S, Harlev D, Fleckenstein B, Hönscheid A, Oommen PT, Kuhlen M, Thiele R, Laws HJ, Borkhardt A, Stepensky P, Fischer U.

Haematologica. 2015 Sep;100(9):1189-98. doi: 10.3324/haematol.2014.114967. Epub 2015 Jun 25.

12.

No evidence for human papillomavirus infection in focal cortical dysplasia IIb.

Coras R, Korn K, Bien CG, Kalbhenn T, Rössler K, Kobow K, Giedl J, Fleckenstein B, Blumcke I.

Ann Neurol. 2015 Feb;77(2):312-9. doi: 10.1002/ana.24328. Epub 2014 Dec 24.

PMID:
25483312
13.

A novel homozygous Fas ligand mutation leads to early protein truncation, abrogation of death receptor and reverse signaling and a severe form of the autoimmune lymphoproliferative syndrome.

Nabhani S, Hönscheid A, Oommen PT, Fleckenstein B, Schaper J, Kuhlen M, Laws HJ, Borkhardt A, Fischer U.

Clin Immunol. 2014 Dec;155(2):231-7. doi: 10.1016/j.clim.2014.10.006. Epub 2014 Oct 24.

PMID:
25451160
14.

The tumor marker Fascin is induced by the Epstein-Barr virus-encoded oncoprotein LMP1 via NF-κB in lymphocytes and contributes to their invasive migration.

Mohr CF, Kalmer M, Gross C, Mann MC, Sterz KR, Kieser A, Fleckenstein B, Kress AK.

Cell Commun Signal. 2014 Jul 11;12:46. doi: 10.1186/s12964-014-0046-x.

15.

The transcription elongation factor ELL2 is specifically upregulated in HTLV-1-infected T-cells and is dependent on the viral oncoprotein Tax.

Mann MC, Strobel S, Fleckenstein B, Kress AK.

Virology. 2014 Sep;464-465:98-110. doi: 10.1016/j.virol.2014.06.028. Epub 2014 Jul 22.

16.

Assessing the citrullinome in rheumatoid arthritis synovial fluid with and without enrichment of citrullinated peptides.

Tutturen AE, Fleckenstein B, de Souza GA.

J Proteome Res. 2014 Jun 6;13(6):2867-73. doi: 10.1021/pr500030x. Epub 2014 Apr 28.

PMID:
24724574
17.

Hypomorphic homozygous mutations in phosphoglucomutase 3 (PGM3) impair immunity and increase serum IgE levels.

Sassi A, Lazaroski S, Wu G, Haslam SM, Fliegauf M, Mellouli F, Patiroglu T, Unal E, Ozdemir MA, Jouhadi Z, Khadir K, Ben-Khemis L, Ben-Ali M, Ben-Mustapha I, Borchani L, Pfeifer D, Jakob T, Khemiri M, Asplund AC, Gustafsson MO, Lundin KE, Falk-Sörqvist E, Moens LN, Gungor HE, Engelhardt KR, Dziadzio M, Stauss H, Fleckenstein B, Meier R, Prayitno K, Maul-Pavicic A, Schaffer S, Rakhmanov M, Henneke P, Kraus H, Eibel H, Kölsch U, Nadifi S, Nilsson M, Bejaoui M, Schäffer AA, Smith CI, Dell A, Barbouche MR, Grimbacher B.

J Allergy Clin Immunol. 2014 May;133(5):1410-9, 1419.e1-13. doi: 10.1016/j.jaci.2014.02.025. Epub 2014 Apr 1.

18.

Specific biotinylation and sensitive enrichment of citrullinated peptides.

Tutturen AE, Holm A, Fleckenstein B.

Anal Bioanal Chem. 2013 Nov;405(29):9321-31. doi: 10.1007/s00216-013-7376-1. Epub 2013 Oct 1.

PMID:
24081567
19.

Inherited human OX40 deficiency underlying classic Kaposi sarcoma of childhood.

Byun M, Ma CS, Akçay A, Pedergnana V, Palendira U, Myoung J, Avery DT, Liu Y, Abhyankar A, Lorenzo L, Schmidt M, Lim HK, Cassar O, Migaud M, Rozenberg F, Canpolat N, Aydogan G, Fleckenstein B, Bustamante J, Picard C, Gessain A, Jouanguy E, Cesarman E, Olivier M, Gros P, Abel L, Croft M, Tangye SG, Casanova JL.

J Exp Med. 2013 Aug 26;210(9):1743-59. doi: 10.1084/jem.20130592. Epub 2013 Jul 29.

20.

HIV-1 fusion is blocked through binding of GB Virus C E2-derived peptides to the HIV-1 gp41 disulfide loop [corrected].

Eissmann K, Mueller S, Sticht H, Jung S, Zou P, Jiang S, Gross A, Eichler J, Fleckenstein B, Reil H.

PLoS One. 2013;8(1):e54452. doi: 10.1371/journal.pone.0054452. Epub 2013 Jan 22. Erratum in: PLoS One. 2014;9(1). doi:10.1371/annotation/b46459e1-73ff-4b75-8f24-264cbcf4a5a9.

21.

Small-scale purification and mass spectrometry analysis reveal a third aquaporin-4 protein isoform of 36 kDa in rat brain.

Sørbø JG, Fleckenstein B, Ottersen OP, Holen T.

J Neurosci Methods. 2012 Oct 15;211(1):31-9. doi: 10.1016/j.jneumeth.2012.07.021. Epub 2012 Aug 7.

PMID:
22967487
22.

The ephrin receptor tyrosine kinase A2 is a cellular receptor for Kaposi's sarcoma–associated herpesvirus.

Hahn AS, Kaufmann JK, Wies E, Naschberger E, Panteleev-Ivlev J, Schmidt K, Holzer A, Schmidt M, Chen J, König S, Ensser A, Myoung J, Brockmeyer NH, Stürzl M, Fleckenstein B, Neipel F.

Nat Med. 2012 Jun;18(6):961-6. doi: 10.1038/nm.2805.

23.

Species restriction of Herpesvirus saimiri and Herpesvirus ateles: human lymphocyte transformation correlates with distinct signaling properties of viral oncoproteins.

Katsch K, de Jong SJ, Schmidt M, Müller-Fleckenstein I, Fleckenstein B, Albrecht JC, Biesinger B.

Virus Res. 2012 May;165(2):179-89. doi: 10.1016/j.virusres.2012.02.014. Epub 2012 Feb 25.

PMID:
22374337
24.

Loss-of-function mutations within the IL-2 inducible kinase ITK in patients with EBV-associated lymphoproliferative diseases.

Linka RM, Risse SL, Bienemann K, Werner M, Linka Y, Krux F, Synaeve C, Deenen R, Ginzel S, Dvorsky R, Gombert M, Halenius A, Hartig R, Helminen M, Fischer A, Stepensky P, Vettenranta K, Köhrer K, Ahmadian MR, Laws HJ, Fleckenstein B, Jumaa H, Latour S, Schraven B, Borkhardt A.

Leukemia. 2012 May;26(5):963-71. doi: 10.1038/leu.2011.371. Epub 2012 Jan 6.

PMID:
22289921
25.

Cell surface markers in HTLV-1 pathogenesis.

Kress AK, Grassmann R, Fleckenstein B.

Viruses. 2011 Aug;3(8):1439-59. doi: 10.3390/v3081439. Epub 2011 Aug 16. Review.

26.

Peptides derived from a distinct region of GB virus C glycoprotein E2 mediate strain-specific HIV-1 entry inhibition.

Koedel Y, Eissmann K, Wend H, Fleckenstein B, Reil H.

J Virol. 2011 Jul;85(14):7037-47. doi: 10.1128/JVI.02366-10. Epub 2011 May 4.

27.

Assessing high affinity binding to HLA-DQ2.5 by a novel peptide library based approach.

Jüse U, Arntzen M, Højrup P, Fleckenstein B, Sollid LM.

Bioorg Med Chem. 2011 Apr 1;19(7):2470-7. doi: 10.1016/j.bmc.2011.01.057. Epub 2011 Feb 2.

PMID:
21382721
28.

Gammaherpesviruses of New World primates.

Fleckenstein B, Ensser A.

In: Arvin A, Campadelli-Fiume G, Mocarski E, Moore PS, Roizman B, Whitley R, Yamanishi K, editors. Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis. Cambridge: Cambridge University Press; 2007. Chapter 60.

29.

Structure-function relationships of the competence lipoprotein ComL and SSB in meningococcal transformation.

Benam AV, Lång E, Alfsnes K, Fleckenstein B, Rowe AD, Hovland E, Ambur OH, Frye SA, Tønjum T.

Microbiology. 2011 May;157(Pt 5):1329-42. doi: 10.1099/mic.0.046896-0. Epub 2011 Feb 17.

30.

The tumor marker Fascin is strongly induced by the Tax oncoprotein of HTLV-1 through NF-kappaB signals.

Kress AK, Kalmer M, Rowan AG, Grassmann R, Fleckenstein B.

Blood. 2011 Mar 31;117(13):3609-12. doi: 10.1182/blood-2010-09-305805. Epub 2011 Feb 7.

31.

Anti-PAD4 autoantibodies in rheumatoid arthritis: levels in serum over time and impact on PAD4 activity as measured with a small synthetic substrate.

Pollmann S, Stensland M, Halvorsen EH, Sollid LM, Kvien TK, Fleckenstein B, Molberg O.

Rheumatol Int. 2012 May;32(5):1271-6. doi: 10.1007/s00296-010-1765-y. Epub 2011 Jan 26.

32.

The preferred substrates for transglutaminase 2 in a complex wheat gluten digest are Peptide fragments harboring celiac disease T-cell epitopes.

Dørum S, Arntzen MØ, Qiao SW, Holm A, Koehler CJ, Thiede B, Sollid LM, Fleckenstein B.

PLoS One. 2010 Nov 19;5(11):e14056. doi: 10.1371/journal.pone.0014056.

33.

Revisiting human IL-12Rβ1 deficiency: a survey of 141 patients from 30 countries.

de Beaucoudrey L, Samarina A, Bustamante J, Cobat A, Boisson-Dupuis S, Feinberg J, Al-Muhsen S, Jannière L, Rose Y, de Suremain M, Kong XF, Filipe-Santos O, Chapgier A, Picard C, Fischer A, Dogu F, Ikinciogullari A, Tanir G, Al-Hajjar S, Al-Jumaah S, Frayha HH, AlSum Z, Al-Ajaji S, Alangari A, Al-Ghonaium A, Adimi P, Mansouri D, Ben-Mustapha I, Yancoski J, Garty BZ, Rodriguez-Gallego C, Caragol I, Kutukculer N, Kumararatne DS, Patel S, Doffinger R, Exley A, Jeppsson O, Reichenbach J, Nadal D, Boyko Y, Pietrucha B, Anderson S, Levin M, Schandené L, Schepers K, Efira A, Mascart F, Matsuoka M, Sakai T, Siegrist CA, Frecerova K, Blüetters-Sawatzki R, Bernhöft J, Freihorst J, Baumann U, Richter D, Haerynck F, De Baets F, Novelli V, Lammas D, Vermylen C, Tuerlinckx D, Nieuwhof C, Pac M, Haas WH, Müller-Fleckenstein I, Fleckenstein B, Levy J, Raj R, Cohen AC, Lewis DB, Holland SM, Yang KD, Wang X, Wang X, Jiang L, Yang X, Zhu C, Xie Y, Lee PP, Chan KW, Chen TX, Castro G, Natera I, Codoceo A, King A, Bezrodnik L, Di Giovani D, Gaillard MI, de Moraes-Vasconcelos D, Grumach AS, da Silva Duarte AJ, Aldana R, Espinosa-Rosales FJ, Bejaoui M, Bousfiha AA, Baghdadi JE, Ozbek N, Aksu G, Keser M, Somer A, Hatipoglu N, Aydogmus C, Asilsoy S, Camcioglu Y, Gülle S, Ozgur TT, Ozen M, Oleastro M, Bernasconi A, Mamishi S, Parvaneh N, Rosenzweig S, Barbouche R, Pedraza S, Lau YL, Ehlayel MS, Fieschi C, Abel L, Sanal O, Casanova JL.

Medicine (Baltimore). 2010 Nov;89(6):381-402. doi: 10.1097/MD.0b013e3181fdd832.

34.

Elevated cyclic AMP levels in T lymphocytes transformed by human T-cell lymphotropic virus type 1.

Kress AK, Schneider G, Pichler K, Kalmer M, Fleckenstein B, Grassmann R.

J Virol. 2010 Sep;84(17):8732-42. doi: 10.1128/JVI.00487-10. Epub 2010 Jun 23.

35.

Redox regulation of transglutaminase 2 activity.

Stamnaes J, Pinkas DM, Fleckenstein B, Khosla C, Sollid LM.

J Biol Chem. 2010 Aug 13;285(33):25402-9. doi: 10.1074/jbc.M109.097162. Epub 2010 Jun 14.

36.

A technique for the specific enrichment of citrulline-containing peptides.

Tutturen AE, Holm A, Jørgensen M, Stadtmüller P, Rise F, Fleckenstein B.

Anal Biochem. 2010 Aug;403(1-2):43-51. doi: 10.1016/j.ab.2010.04.012. Epub 2010 Apr 23.

PMID:
20399192
37.

Gluten T cell epitope targeting by TG3 and TG6; implications for dermatitis herpetiformis and gluten ataxia.

Stamnaes J, Dorum S, Fleckenstein B, Aeschlimann D, Sollid LM.

Amino Acids. 2010 Nov;39(5):1183-91. doi: 10.1007/s00726-010-0554-y. Epub 2010 Mar 19.

PMID:
20300788
38.

Design of new high-affinity peptide ligands for human leukocyte antigen-DQ2 using a positional scanning peptide library.

Jüse U, van de Wal Y, Koning F, Sollid LM, Fleckenstein B.

Hum Immunol. 2010 May;71(5):475-81. doi: 10.1016/j.humimm.2010.01.021. Epub 2010 Feb 6.

PMID:
20105447
39.

HIV-1 seroreversion following antiretroviral therapy in an HIV-infected child initially presenting with acquired immunodeficiency syndrome.

Neubert J, Laws HJ, Adams O, Münk C, Krämer M, Niehues T, Korn K, Fleckenstein B, Petri E, Borkhardt A.

AIDS. 2010 Jan 16;24(2):327-8. doi: 10.1097/QAD.0b013e328334cc60. No abstract available.

PMID:
20029271
40.

[The German Excellence Initiative : effects on the medical schools].

Fleckenstein B.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2009 Sep;52(9):940-8. doi: 10.1007/s00103-009-0921-6. German.

PMID:
19685216
41.

Targeted analysis of protein citrullination using chemical modification and tandem mass spectrometry.

Stensland M, Holm A, Kiehne A, Fleckenstein B.

Rapid Commun Mass Spectrom. 2009 Sep;23(17):2754-62. doi: 10.1002/rcm.4185.

PMID:
19639564
42.

Transformation efficiency by Herpesvirus saimiri is not a limiting factor in clonal CD8pos T cell outgrowth.

Lehner M, Grillhoesl C, Full F, Vogel B, Weller P, Müller-Fleckenstein I, Schmidt M, Fleckenstein B, Holter W, Ensser A.

Virology. 2009 May 25;388(1):15-20. doi: 10.1016/j.virol.2009.03.013. Epub 2009 Apr 17.

43.

Identification of neisserial DNA binding components.

Lång E, Haugen K, Fleckenstein B, Homberset H, Frye SA, Ambur OH, Tønjum T.

Microbiology. 2009 Mar;155(Pt 3):852-62. doi: 10.1099/mic.0.022640-0.

44.

A quantitative analysis of transglutaminase 2-mediated deamidation of gluten peptides: implications for the T-cell response in celiac disease.

Dørum S, Qiao SW, Sollid LM, Fleckenstein B.

J Proteome Res. 2009 Apr;8(4):1748-55. doi: 10.1021/pr800960n.

PMID:
19239248
45.

Primary sequence, together with other factors, influence peptide deimination by peptidylarginine deiminase-4.

Stensland ME, Pollmann S, Molberg Ø, Sollid LM, Fleckenstein B.

Biol Chem. 2009 Feb;390(2):99-107. doi: 10.1515/BC.2009.019.

PMID:
19040354
46.

Soluble HLA-DQ2 expressed in S2 cells copurifies with a high affinity insect cell derived protein.

Jüse U, Fleckenstein B, Bergseng E, Sollid LM.

Immunogenetics. 2009 Feb;61(2):81-9. doi: 10.1007/s00251-008-0338-7. Epub 2008 Nov 6.

PMID:
18987854
47.

Complexes of two cohorts of CLIP peptides and HLA-DQ2 of the autoimmune DR3-DQ2 haplotype are poor substrates for HLA-DM.

Fallang LE, Roh S, Holm A, Bergseng E, Yoon T, Fleckenstein B, Bandyopadhyay A, Mellins ED, Sollid LM.

J Immunol. 2008 Oct 15;181(8):5451-5461. Erratum in: J Immunol. 2009 Jan 1;182(1):726.

48.

The monoclonal antibody 6B9 recognizes CD44 and not cell surface transglutaminase 2.

Stamnaes J, Fleckenstein B, Lund-Johansen F, Sollid LM.

Scand J Immunol. 2008 Nov;68(5):534-42. doi: 10.1111/j.1365-3083.2008.02173.x. Epub 2008 Sep 18.

49.

The propensity for deamidation and transamidation of peptides by transglutaminase 2 is dependent on substrate affinity and reaction conditions.

Stamnaes J, Fleckenstein B, Sollid LM.

Biochim Biophys Acta. 2008 Nov;1784(11):1804-11. doi: 10.1016/j.bbapap.2008.08.011. Epub 2008 Aug 28.

50.

Ligand binding and antigenic properties of a human neonatal Fc receptor with mutation of two unpaired cysteine residues.

Andersen JT, Justesen S, Fleckenstein B, Michaelsen TE, Berntzen G, Kenanova VE, Daba MB, Lauvrak V, Buus S, Sandlie I.

FEBS J. 2008 Aug;275(16):4097-110. doi: 10.1111/j.1742-4658.2008.06551.x. Epub 2008 Jul 15.

Supplemental Content

Loading ...
Support Center